Clinical trial · Observational
Correlation Between COVID-19 and Radiation Pneumonitis in Breast Cancer
Correlation Between COVID-19 and Radiation Pneumonitis in Breast Cancer: A Historical Cohort Study
NCT07188116CI-TRIAL-00095611not yet recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study was designed as a single-center retrospective analysis aimed at investigating whether COVID-19 infection increases the risk or burden of radiation-induced pneumonitis in breast cancer patients.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| COVID-19 | — | UNRESOLVED | — |
| Radiation Pneumonia | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| COVID-19 | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Without COVID-19
- description
- No COVID-19 infection
- interventionNames
- Other: COVID-19
- label
- With COVID-19
- description
- With COVID-19 infection
- interventionNames
- Other: COVID-19
Primary outcomes (1)
- measure
- Radiation Pneumonitis Situation
- timeFrame
- From January 2021 to June 2024
- description
- The incidence rate, severity and onset time of radiation pneumonitis
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: 1. patients with pathologically or cytologically confirmed primary breast cancer, 2. aged 18 years or older but younger than 80 years, 3. with complete and reliable medical records, 4. for those with COVID-19 infection, documented evidence of a positive test result. Exclusion Criteria: 1. concomitant pulmonary malignancies, 2. a history of prior thoracic radiotherapy, 3. concurrent pulmonary infections other than COVID-19 during radiotherapy, 4. missing key data with loss to follow-up, 5. or any other condition considered unsuitable for enrollment by the investigators.
References
Publications (0)
Data not yet available
No reference posted for this study.